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Summary
Introduction: Sudden retinal blindness is a common complication of temporal arteritis (TA).
Another common cause is embolic occlusion of the central retinal artery (CRA). The aim of this
prospective study was to examine the diagnostic value of hyperechoic material in the CRA for
exclusion of vasculitis as a cause. The authors used orbital color-coded sonography (OCCS) for
the detection of hyperechoic material.
Materials and methods: Twenty-four patients with sudden visual loss were included in the study
after opthalmoscopic exclusion of other causes (e.g. vitreous bleeding, retinal detachment).
Parallel to routine diagnostic workup OCCS was performed in all patients.
Results: 7 patients with the diagnosis of TA presented with different degrees of hypoperfusion
in the CRA without hyperechoic material (referred to as a ‘‘spot sign’’) detected by OCCS.
Diagnostic workup in the remaining 17 patients did not reveal any signs of TA. The hyperechoic
spot sign was visible in 10 of 12 patients (83%) with embolic CRA occlusion. Altogether the
frequency of the spot sign in this group was 59%.
Detection of embolic CRAO using the spot sign had a sensitivity of 83% and a speciﬁcity of
100%. The missing spot sign in patients with TA was a highly speciﬁc ﬁnding (p-value 0.01).
Conclusions: The ‘‘spot sign’’ is a highly speciﬁc ﬁnding, and its detection excludes the diagnosis
of temporal arteritis in patients
patients from receiving long-te
with its immanent risks.
© 2012 Elsevier GmbH.
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on the basis of other pathologies. Patients were then further
sorted depending on their funduscopic ﬁndings.The retrobulbar spot sign in sudden blindness — Sufﬁcient to
Introduction
Sudden retinal blindness is a common complication of tem-
poral arteritis (TA) due to ischemic optic neuropathy (ION)
caused by vasculitic occlusion of the central retinal artery
(CRA), the posterior ciliary artery (PCA) and other orbital
arteries [1]. Depending on the affected arteries central
retinal artery occlusion (CRAO), anterior optic neuropa-
thy (AION) or posterior optic neuropathy (PION) are the
results. In the elderly other common causes for hypoper-
fusion of the retina are thromboembolic events [2,3]. As a
tool for the detection of TA, high-resolution ultrasonogra-
phy of the superﬁcial temporal artery has had a signiﬁcant
impact, with a high positive predictive value for the diag-
nosis of TA (speciﬁcity of 91%). However, a missing ‘‘halo’’
sign, suggestive for vessel wall inﬂammation seen on ultra-
sonography, does not sufﬁciently rule out presence of the
disease (sensitivity 68%) and, therefore, superﬁcial tempo-
ral artery biopsy remains the gold standard in the diagnosis
of TA [4]. The differentiation of embolic versus arteritic
occlusion remains a diagnostic challenge in elderly patients
with ischemic optic neuropathy, because symptoms of TA,
such as headache and elevation of inﬂammatory param-
eters, often coexist with signiﬁcant cerebrovascular risk
proﬁles. Additionally, depending on the cause of occlu-
sion, different acute management strategies need to be
applied quickly to improve long-term outcomes in these
patients.
It is evident that we still need additional criteria with
high negative predictive values to exclude the presence of
vasculitis.
In a previously published series of patients with crite-
ria for TA and sudden blindness, we found a hyperechoic
embolic occlusion of the CRA in the area of the optic
nerve head, which could be used to exclude TA; we
called this a retrobulbar ‘‘spot sign’’ [5]. Foroozan et al.
published a series of 29 patients with acute vision loss
irrespective of the criteria for TA and observed this
phenomenon in 9 patients with central retinal artery occlu-
sion (CRAO) detected by retinal ﬂuorescence angiography
[6].
High-resolution color-coded ultrasonography can also
be applied to the orbit since vitreous gel does not lead
to any signiﬁcant absorption of the incidental ultrasound
beam. Orbital color-coded sonography (OCCS) allows detec-
tion of retrobulbar arteries and veins in addition to an
assessment of orbital structures [7]. An analysis of Doppler
ﬂow spectra further aids the assessment and, to some
degree the quantiﬁcation, of retinal hypoperfusion due
to CRA stenosis or occlusion. Normal ﬂow velocity val-
ues within the CRA have been established previously
[8].
This is the ﬁrst prospective study in which patients
suffering from acute vision loss due to either thromboem-
bolic events or vasculitic changes in vessel walls were
examined to identify the frequency of the ‘‘spot sign’’
in these speciﬁc disease patterns. We demonstrate that
OCCS can be used to signiﬁcantly discriminate embolic CRAO
from arteritic causes of sudden ocular blindness in the
elderly. wout vasculitis? 409
aterials and methods
opulation and study protocol
he study protocol was approved by the local ethics com-
ittee at the University of Regensburg in accordance
ith the Declaration of Helsinki. Patients were ﬁrst seen
nd screened at the Department of Ophthalmology of the
niversity Hospital Regensburg. After exclusion of other rea-
ons for visual loss, such as vitreous bleeding or retinal
etachment, patients were referred to the Department of
eurology for OCCS and a routine neurovascular workup that
ncluded assessment of the superﬁcial temporal artery. The
unduscopic results were not disclosed before OCCS was per-
ormed. Before enrollment in the study, patients were made
ware of the noninvasive and safe nature of OCCS and pro-
ided their written informed consent. In accordance with
he study protocol, patients underwent routine diagnostic
orkups in the Departments of Ophthalmology and Neurol-
gy at our hospital, including registration of cerebrovascular
isk factors, laboratory tests to detect criteria associated
ith TA (including the erythrocyte sedimentation rate [ESR])
ccording to American College of Rheumatology (ACR) crite-
ia, a visual acuity test, retinal fundoscopy and color-coded
onography of brain-supplying arteries. All tests were per-
ormed within 24 h after admission.
ltrasound equipment and data acquisition
or the visualization of retrobulbar structures, a high-
esolution linear-array transducer with frequencies ranging
rom 8 to 15MHz was used in combination with a Siemens
cuson system (Siemens AG, Erlangen, Germany) and a
oshiba XarioXG device (Toshiba, Tokyo, Japan). The acous-
ic output of the ultrasound systems was adjusted to the
equirements of orbital sonography according to the ALARA
rinciple (‘‘as low as reasonably achievable’’) to avoid dam-
ge to the lens and retina [9]. The settings for orbital
onography were the following: for B-mode, transmit fre-
uency 14MHz, mechanical index (MI) = 0.1, single focal
one at 2.5 cm, and bandwidth 74 dB; for C-mode, trans-
it frequency 10MHz, MI = 0.2, color scale optimized for
ow velocities, and no wall ﬁlter; and for PW-mode, transmit
requency 2MHz and MI < 0.44.
For OCCS the patients were placed supine with their eyes
losed and asked to gaze forward. From above and slightly
ateral, the transducer was placed with minimal pressure on
he patient’s orbit using plenty of contact gel. By deﬁnition
he nasal side is depicted on the left image side.
atient groups and statistical analysis
epending on the ﬁnal diagnosis and speciﬁc ﬁndings,
atients were sorted into two different groups: (1) patients
ith a ﬁnal diagnosis of TA; and (2) patients with visual lossThe frequency of the retrobulbar ‘‘spot sign’’ in patients
ith TA (group 1) was compared with that in patients
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ithout TA (group 2) by using a 2× 2 table. A subgroup anal-
sis was performed for patients with CRAO in funduscopy
n both groups. Data analysis was performed using statisti-
al software (IBM SPSS Statistics, Version 18, 2009, Armonk,
SA). The independence of both variables (vasculitis and
‘spot sign’’) was tested using the exact Fisher test. Sensitiv-
ty and speciﬁcity were calculated including their respective
onﬁdence intervals.
esults
etween June 2010 and June 2011 we enrolled 24 patients
ith monocular blindness in this prospective study.
Group 1: 7 patients (3 male and 4 female) had reti-
al hypoperfusion due to TA. All 7 patients had 3 or more
ositive ACR criteria. In all but one patient, fundoscopic
xamination demonstrated AION with a blurred rim of the
ptic disc with optic disc edema and hyperemia with or
ithout small splinter hemorrhages (Fig. 1d).
One patient had ﬁndings equivalent to CRAO, the diag-
osis of TA was validated years before on the basis of ACR
riteria by the Department of Rheumatology.
In 3 of the 7 patients we found a halo sign in the ipsilat-
ral and/or contralateral superﬁcial temporal artery during
he ultrasound examination. The diagnosis was conﬁrmed
n 4 of 7 patients by means of temporal artery biopsy. In
patient, who was unable to undergo biopsy because of
ngoing anticoagulation therapy with warfarin, a positive
‘halo’’ sign was identiﬁed in the left temporal artery. One
atient had 4 out of 5 positive ACR-criteria but a negative
nding in temporal artery biopsy. None of the patients in this
roup had a retrobulbar spot sign, but there was absent or
seudovenous ﬂow in the CRA (Fig. 1a—c). Arterial hyper-
ension was present in 4 patients, diabetes mellitus in 2
atients, hypercholesterolemia in 1 patient, and atrial ﬁb-
illation (AFIB) in a single patient who was treated with
arfarin accordingly. One patient was a former smoker.
he average number of risk factors per patient in this
roup was 2.
Group 2: 17 patients (8 male and 9 female) had sudden
onocular blindness based on other pathologies than TA.
12 patients had CRAO in funduscopy. In 2 female patients
e found typical fundoscopic ﬁndings of anterior ischemic
ptic neuropathy (AION). One male patient had small splin-
er hemorrhages in funduscopy but normal ﬂow in both CRAs,
robably as a result of recanalized CRAO. One male patient
ad an occlusion of a big retinal artery (CRA branch) with
bsent ﬂow in the CRA, based on an ipsilateral ICA occlusion
ith collateralization from the contralateral ICA. One male
atient with risk factors of hypertension, former tobacco
se, and hyperuricemia, had a 90% stenosis (graded accord-
ng to ECST criteria [10]) in the left ICA and visual loss in
he left eye due to hypoperfusion of the left CRA; he was
eferred to vascular surgeons for carotid endarterectomy.
All of these patients had a maximum of 2 positive ACR
riteria. On OCCS 10 (59%) of 17 patients had a visible hyper-
choic plaque, known as ‘‘spot sign,’’ at the tip of the CRA;
aken in account only the patients with CRAO in funduscopy
n this group, 10 of 12 patients (83%) had a visible ‘‘spot
ign’’ and absent arterial ﬂow (Fig. 2a and b). Moderate ipsi-
ateral ICA stenosis (50—60% according to ECST criteria) was
s
o
s
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resent in three patients (27%) and an additional 3 patients
ad contralateral ICA stenosis.
The average number of risk factors per patient in this
roup was 2.2. Arterial hypertension was present in 14
atients, AFIB in 2 and hypercholesterolemia in 7. Six
atients had a history of smoking, 1 patient had hyper-
ricemia and 1 patient had comorbid migraine. Both of the
atients with AFIB also had ICA stenosis on the ipsilateral
ide (both measuring 60% according to ECST criteria).
Summarizing, no patient with TA had a visible spot sign.
The spot sign was detectable in 10 out of 13 patients (73%)
ith CRAO. With the exception of one patient, CRAOs were
ot associated with TA. Taken in account only the patients
ith embolic CRAO (12 out of 13) the spot sign was present
n 83% of the cases. No spot sign could be seen in patients
ith other forms of ischemic optic neuropathy (e.g. AION,
etinal artery branch occlusion).
tatistical analysis
sing the exact Fisher test comparing the frequency of the
pot sign in TA and non-TA patients we found a p-value of
.01, the sensitivity of detecting embolic CRAO using the
‘spot sign’’ was 83% (95% CI: 65—99%). The speciﬁcity for
mbolic occlusions was 100% (95% CI: 65—100%).
iscussion
n this prospective study we demonstrate the diagnostic
igniﬁcance of retrobulbar ultrasonography for the differ-
ntiation of embolic and vasculitic causes of ischemic optic
europathy.
The causes for ION can be subdivided into different
roups, depending on the affected retinal arteries: CRAO,
ION and PION [11]. TA, embolism or hypoperfusion are
esponsible for retinal ischemia in all subgroups. Reliable
echniques to discriminate between the different forms are
unduscopy and ﬂuorescence angiography. Moreover FA can
e helpful to show delayed ﬁlling or vascular leakage in
horoidal vessels in AION for example. However, both meth-
ds cannot elicitate the underlying etiology because they
ack sensitivity or depth penetration beyond the retina and
hus cannot elucidate the underlying cause of ION.
Temporal arteritis (Horton disease or giant cell arteritis)
nd embolism from cerebrovascular disease require differ-
nt acute and long-term therapeutic managements: for an
mbolic event, anticoagulation or platelet inhibition plus
ontrol of vascular risk factors should be initiated; whereas
n TA, rapid initiation and long-lasting steroid therapy is
ssential. Due to the signiﬁcant side effects of long-term
teroid treatment, it is clear that a correct diagnosis is
andatory. So far, the only valid list of diagnostic crite-
ia for TA has been established by the American College of
heumatology. According to the ACR, 3 or more of the fol-
owing criteria must be present for a diagnosis of TA: (1) age
f 50 years or older; (2) new onset of localized headache; (3)
emporal artery tenderness on palpation or decreased pul-
ation; (4) ESR of 50mm/h or higher; (5) abnormal ﬁndings
f a temporal artery biopsy. The sensitivity for this diagno-
is was reported to be 93.5%, with a speciﬁcity of 91.2% for
he discrimination of giant cell arteritis from other forms
The retrobulbar spot sign in sudden blindness — Sufﬁcient to rule out vasculitis? 411
Figure 1 Ultrasound and funduscopic ﬁndings in patients with CRAO due to temporal arteritis. (a) Patient 1: a 84-year-old woman
with visual loss for 2 days. Duplex- and color-mode OCCS images showing reduced ﬂow in the affected CRA. (b) Patient 1: Duplex-
and color-mode OCCS images showing normal ﬂow in the unaffected contralateral CRA. (c) Patient 2: a 71-year-old man with visual
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image showing a blurred rim of the optic disc, optic disc edema
of vasculitis [12]. The main disadvantage of these criteria
is that they were not developed and validated for diagnosis
in the general population [13]. Secondly, a temporal artery
biopsy with its immanent risks can provide false-negative
results because of the possible ‘‘skip lesion’’ type of dis-
tribution of vasculitis-induced changes in the vessel wall.
High-resolution ultrasonography of the superﬁcial temporal
artery has been proposed as an adjunct diagnostic tool in
the workup of TA, and, indeed, an unequivocal ﬁnding of the
halo sign has a high positive predictive value of > 90% [4].
Unfortunately, however, no halo ﬁnding does not sufﬁciently
rule out presence of the disease.
Embolic artery occlusions are mainly due to atheroscle-
rotic changes in the vessel wall, cardioembolism, or
pathologies of the aortic arch [6]. Well-characterized
risk factors for cerebral arterial occlusive diseases are
hypertension, atrial ﬁbrillation, coronary artery disease,
diabetes mellitus, hypercholesterolemia, and tobacco use
[14]. Within our patient groups an approximate mean of
2 of the aforementioned risk factors were present inde-
pendent of the eventual cause of the occlusion. This
underlines the inability to discriminate vasculitic from
embolic causes of CRAO according to a speciﬁc risk
proﬁle.
C
s
i
cing zero ﬂow in the affected CRA. (d) Patient 2: Funduscopic
hyperemia, as well as a small splinter hemorrhage.
The presence of the spot sign is highly suggestive for
mbolism, whereas vasculitic hypoperfusion is represented
y absent or low-ﬂow only. We found OCCS to be a highly
peciﬁc tool in the further discrimination of these disease
atterns in patients with sudden visual loss. The sensi-
ivity of detecting embolic CRAO using the spot sign was
3% (95% CI: 65—99%), with a speciﬁcity of 100% (95% CI:
5—100%) to rule out vasculitic causes of ION. The missing
pot sign in patients with TA was a highly signiﬁcant ﬁnding
p = 0.01) despite the relatively small patient sample size.
hus, retrobulbar ultrasonography, an easy, safe, and rapid
echnique, should be considered in the workup in cases of
udden retinal blindness.
The only two retrospective studies of patients with sud-
en monocular blindness seem to have underestimated
he frequency of the retrobulbar hyperechoic plaque, here
eferred to as the ‘‘spot sign’’. In the previously mentioned
tudy by Foroozan et al. [6], the authors found the spot sign
n 31% of patients using OCCS. In the second study, Ahuja
t al. did not see any visible emboli in 18 patients with
RAO [14]. However, Ahuja et al. did not use OCCS in their
tudy; they used only fundoscopy, a technique that visual-
zes typical signs of CRAO but no underlying pathological
haracteristics beyond the retinal level.
412 M. Ertl et al.
Figure 2 Ultrasound ﬁndings in a 77-year-old patient with embolic CRAO and visual loss for 3 days. (a) B-mode: hyperechogenic
‘‘spot sign’’ in the optic nerve head, representing an embolus in the distal CRA. (b) Duplex- and color-mode OCCS image depicting
absent ﬂow in the CRA. (c) Duplex- and color-mode OCCS image demonstrating normal ﬂow in the unaffected contralateral CRA.
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The presence of a spot sign on OCCS should lead to
detailed workup looking for sources of cardiac emboli
electrocardiography, echocardiography, long-term electro-
ardiography, and holter monitoring) and atherosclerosis
intima-media thickness measurements using carotid ultra-
onography, presence of hemodynamically relevant carotid
tenoses, and so forth). This may also prevent patients with
borderline diagnosis of giant cell arteritis (age >50 years,
eadache, elevated ESR due to other causes, or patients
ith ongoing steroid treatment obscuring the diagnosis)
rom receiving long-term steroid treatment with all its neg-
tive side effects or an invasive temporal artery biopsy with
ts immanent risks such as scalp necrosis [15] and facial
erve injury [16,17].
onclusion
n summary, OCCS is a widely accessible method that can
e used to discriminate different causes of sudden monoc-
lar blindness. Safety is ensured by the aforementioned
echnical modiﬁcations. Presence or absence of the ‘‘spot
ign’’ helps to further discriminate embolic from vasculitical ﬁnding of a pale retina with a cherry-red macula (cherry-red
cclusion of the CRA. The expenditure of time for the exam-
nation is short and the technique is easily applied, even in
he hands of less-experienced ultrasonographers.
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